- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 0 sh |
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 0 sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $7.7M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $78.14M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $275.16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $177.35M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.12B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.01B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $82.95M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $77.05M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $142.72M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $139.34M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $422.06M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $384.65M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.29B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.17B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 255.46M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.44M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $10.04M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $20.72M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $37.68M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.9M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$166K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $74.54M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $28.18M |
| Revenue | Q1 2025 · Mar 31, 2024 | $102.72M |